Why the study?
Are plasma atrial natriuretic peptide concentrations elevated in cardiac transplant recipients compared to matched controls?
Are plasma atrial natriuretic peptide concentrations elevated in cardiac transplant recipients compared to matched controls?
Cardiac transplant recipients have significantly elevated plasma atrial natriuretic peptide concentrations, suggesting that cardiac innervation is not obligatory for ANP secretion.
Supports non-neural ANP secretion post-denervation; hypothesis-generating and should not yet change clinical monitoring.
Plasma atrial natriuretic peptide concentrations were measured by radioimmunoassay six to 77 weeks after operation in eight cardiac transplant recipients with no appreciable evidence of cardiac failure or rejection and in eight control subjects matched for age, sex, race, and blood pressure. Plasma atrial natriuretic peptide concentrations were significantly higher in the cardiac transplant recipients (mean 19.4 (SE 3.9) ng/l) than in the controls (7.3 (1.2) ng/l p less than 0.01). The mechanisms underlying these raised values were not clear. These findings suggest that the transplanted atria may secrete atrial peptides and also that innervation is not obligatory for secretion of atrial natriuretic peptides to occur. Before this can be confirmed, however, it remains to be established what the relative contribution of donor and recipient atrial tissue is to the secretion of these peptides.
No takes yet. Share an insight, caveat, or question.
Singer et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: